Martin A Horstmann

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Venues

Leukemia

The Journal of experimental medicine

Blood advances

University Medical Center Hamburg-Eppendorf

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Medical Center Hamburg-Eppendorf

Germany

Director Research Institute :: Pediatric Oncology and Hematology

Publications

Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Anthony V Moorman, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L Den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne Vibeke Hansen Marquart, Kjeld Schmiegelow, Jeremy Hancock, John P Moppett, Mats Heyman
Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia 38 (9) (2024)
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P Zahedi, Irmela Jeremias, Albert Sickmann, Peter Nollau, Martin A Horstmann
Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood advances 2 (19) (2019)
Matthew T Witkowski, Yifang Hu, Kathryn G Roberts, Judith M Boer, Mark D McKenzie, Grace J Liu, Oliver D Le Grice, Cedric S Tremblay, Margherita Ghisi, Tracy A Willson, Martin A Horstmann, Iannis Aifantis, Luisa Cimmino, Seth Frietze, Monique L Den Boer, Charles G Mullighan, Aaron T L Lun, Ross A Dickins
Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome. The Journal of experimental medicine 214 (3) (2017)

Martin A Horstmann.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin A Horstmann